Dr. Bart van der Worp
Dr. Van Der Worp
Bart van der Worp is a neurologist with a special interest in cerebrovascular diseases at the University Medical Center in Utrecht, the Netherlands. He is a member of the recently founded Dutch CONTRAST consortium which aims to identify and test new treatments.
Dr. Bart van der Worp has been (co-)Chief Investigator of the randomised clinical trials HAMLET, PAIS, COOLIST, and VAST and is (co-)Chief Investigator of PRECIOUS (www.precious-trial.eu), EuroHYP-1 (www.eurohyp1.eu), APACHE-AF (www.apache-af.nl), and – starting shortly – MR ASAP.
He is a member of the recently founded Dutch CONTRAST consortium which aims to identify and test new treatments for patients with acute ischaemic stroke or intracerebral haemorrhage, a.o. via a range of follow-up trials to MR CLEAN. Three years of preclinical work in the 1990s have aroused his interest in the translation of findings from animal stroke studies to clinical trials, which he aims to improve together with other members of CAMARADES (www.dcn.ed.ac.uk/camarades) and Multi-PART (www.dcn.ed.ac.uk/multipart).
Other Executive Comittee Members
Dr. Valeria Caso
Valeria Caso is a stroke neurologist at the University of Perugia Stroke Unit. She earned her PhD from the University of Perugia in stroke medicine in 2003 and has been recently certified in the role of associate professor in Neurology.
Prof. Urs Fischer
Urs Fischer has trained in Bern (CH), London (UK), San Francisco (USA) and Lomé (Togo), and he is Professor of Neurology at the University Hospital (Inselspital), Bern. He is the Head of the Neurological Emergency Team, which treats more than 1400 stroke patients per year.